Certified by Founder Lodge
TrialSpark
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $10,000,000
1 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
TrialSpark is a technology company that helps bring treatments to patients faster.
Today, clinical trials are the bottleneck to bringing life-saving treatments to patients. Trials are slow
January
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
